10/29/2024 4:01 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 1:12 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 7:06 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 3:42 PM | BML Investment Partners, L.P. (Filed by) Oramed Pharmaceuticals (Subject)
| Form SC 13G | |
06/26/2024 8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:15 PM | Gabay Avraham (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/20/2024 6:32 AM | Oramed Pharmaceuticals (Filer)
| Form ARS | |
06/20/2024 6:30 AM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A | |
06/10/2024 4:28 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 4:15 PM | Oramed Pharmaceuticals (Issuer) Reznick Yehuda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 7:07 PM | Oramed Pharmaceuticals (Issuer) Reznick Yehuda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 4:30 PM | Oramed Pharmaceuticals (Issuer) Reznick Yehuda (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/22/2024 8:30 PM | KIDRON NADAV (Filed by) Oramed Pharmaceuticals (Subject)
| Form SC 13D | |
03/19/2024 7:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 4:15 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 7:42 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:42 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2024 4:30 PM | Aghion Daniel (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2024 3:45 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:45 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 3:36 PM | Oramed Pharmaceuticals (Issuer) Rozov Yadin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:37 PM | Oramed Pharmaceuticals (Issuer) Sank Leonard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:39 PM | Oramed Pharmaceuticals (Issuer) Silberman David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:40 PM | Hexter Joshua (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:41 PM | KIDRON NADAV (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:43 PM | Kidron Miriam (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:32 PM | Oramed Pharmaceuticals (Issuer) Shapiro Benjamin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:33 PM | Aghion Daniel (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:34 PM | Mayer Arie (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 12:13 PM | Aghion Daniel (Reporting) Oramed Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/21/2023 8:26 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:45 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 4:10 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |